SCHEMBL17396544

SCHEMBL17396544

COc1ccc([C@]23Oc4cc(OC)cc(OC)c4[C@H]2[C@H]2OC(N)=N[C@@H]2[C@H]3c2ccccc2)cc1

nearest known ligand 0.47

Predicted protein targets (top 13)

geneUniProtsupporting neighboursconfidence
▸ CYP3A4 P08684 2/20 0.47
▸ ALDH1A1 P00352 1/20 0.47
▸ TSHR P16473 1/20 0.47
▸ CYP2C19 P33261 1/20 0.47
▸ ABHD10 Q9NUJ1 1/20 0.44
▸ MEN1 O00255 1/20 0.43
▸ KMT2A Q03164 1/20 0.43
▸ ATM Q13315 1/20 0.43
▸ NPSR1 Q6W5P4 1/20 0.43
▸ EIF4A1 P60842 15/20 0.43
▸ NFKB1 P19838 1/20 0.43
▸ RELA Q04206 1/20 0.43
▸ HIF1A Q16665 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24180245 0.78 CYP3A4 (0.45) CYP3A4ALDH1A1TSHRCYP2C19ABHD10
SCHEMBL20006140 0.78 CYP3A4 (0.49) CYP3A4ALDH1A1TSHRCYP2C19ABHD10
SCHEMBL20006458 0.74 CYP3A4 (0.46) CYP3A4ALDH1A1TSHRCYP2C19ABHD10
SCHEMBL20006092 0.74 EIF4A1 (0.51) CYP3A4ALDH1A1TSHRCYP2C19ABHD10
SCHEMBL20006494 0.73 ABHD10 (0.57) CYP3A4ABHD10EIF4A1NFKB1RELA
SCHEMBL20006501 0.73 CYP3A4 (0.47) CYP3A4ALDH1A1TSHRCYP2C19ABHD10
SCHEMBL29532250 0.72 ABHD10 (0.71) CYP3A4ABHD10EIF4A1NFKB1RELA
SCHEMBL17414107 0.72 ABHD10 (0.71) CYP3A4ABHD10EIF4A1NFKB1RELA
SCHEMBL18836092 0.72 ABHD10 (0.71) CYP3A4ABHD10EIF4A1NFKB1RELA
SCHEMBL20006331 0.71 CYP3A4 (0.41) CYP3A4ALDH1A1TSHRCYP2C19ABHD10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3164393-A1 FLAVAGLINE DERIVATIVES Pierre Fabre Médicament (FR) 2017-05-10 — — EP disclosed
WO-2016001441-A1 FLAVAGLINE DERIVATIVES PIERRE FABRE MEDICAMENT (FR) 2016-01-07 — — WO disclosed
Send feedback